Portland, OR, United States of America

Brendan Curti


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brendan Curti: Innovator in Cancer Treatment

Introduction

Brendan Curti is a notable inventor based in Portland, Oregon, recognized for his contributions to cancer treatment methodologies. His innovative approach focuses on utilizing OX40 agonists, which are powerful immune-stimulating agents, to enhance the treatment and monitoring of cancer patients.

Latest Patents

Brendan Curti holds a patent for "Cancer treatment and monitoring methods using OX40 agonists." This patent outlines methods for treating cancer patients by employing OX40 agonists to predict clinical outcomes. The correlation between treatment and an increase in OX40-induced T cell proliferation is a significant aspect of his work. He has 1 patent to his name.

Career Highlights

Curti is affiliated with Providence Health & Services - Oregon, where he applies his expertise in cancer research and treatment. His work is pivotal in advancing the understanding of immune responses in cancer therapy.

Collaborations

Brendan collaborates with esteemed colleagues, including Magdalena Kovacsovics-Bankowski and Ed Walker, to further enhance cancer treatment strategies.

Conclusion

Brendan Curti's innovative work in cancer treatment using OX40 agonists represents a significant advancement in the field. His contributions are vital for improving patient outcomes and understanding immune responses in cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…